GSTM5 as a Potential Biomarker for Treatment Resistance in Prostate CancerGSTM5作为前列腺癌治疗抵抗的潜在生物标志物Biomedicines 2025, Vol. 13, Page 1872IF3.92025-08-210PRE
Exposure to environmental pollutants and genetic variants related to oxidative stress and xenobiotic metabolism-Association with prostate cancerENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGYIF4.22024-06-011PRE
Multi-omic study to unmask genes involved in prostate cancer development in a multi-case familyCANCER COMMUNICATIONSIF24.92023-11-210OAAI
Genetic variants of antioxidant and xenobiotic metabolizing enzymes and their association with prostate cancer: A meta-analysis and functional in silico analysisSCIENCE OF THE TOTAL ENVIRONMENTIF82023-11-014PRE
Ejaculation Frequency and Prostate Cancer: CAPLIFE StudyWORLD JOURNAL OF MENS HEALTHIF4.12023-01-013OAAI
Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate CancerBIOMEDICINESIF3.92021-06-0516OAAI
Genetic variants in xenobiotic detoxi fication enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancerSCIENCE OF THE TOTAL ENVIRONMENTIF82020-08-0110PREAI
Dietary Diversity and Prostate Cancer in a Spanish Adult Population: CAPLIFE StudyNUTRIENTSIF52020-06-067OAAI
Recent clinical relevance of mono-genital colonization/infection by Ureaplasma parvumEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASESIF32020-05-216PREAI
Compliance with the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and Prostate CancerNUTRIENTSIF52020-03-1421OAAI
Primary treatment of painful varicocoele through percutaneous retrograde embolization with fibred coilsANDROLOGYIF3.42014-07-3023OAAI